Related Image: DOE Labs Take Pride in Award-Winning IBM Blue Gene Series |
(Date:11/23/2009)...ABY,BC,Nov.23/PRNewswire/-InimexPharmaceuticals,In...Ph.DasitsPresidentandCEO. ,, Abramsbringsmoreth...Inimex.Heisaco-inventorofthenuclearmedicineimaging...atthey,plcwherehewasManager,BiomedicalResearchWorl...angley,BCandwasPresidentandCEOfrom1996to2006.AnorM...
(Date:11/20/2009)...Latin American countries have an opportunity to ta...searchers from the University of Valencia (UV), wo...tudied the productive fabric of the Spanish biotec... food and plant sectors have more clout than those...as applied to food and plants has been overlooked ...
(Date:11/20/2009)..., SEATTLE, Nov. 20 Cell...nnounced today that the Ninth Circuit Court of App...d that CTI should be allowed to pursue all of its ...ck to the District Court for trial. CTI filed a c...d-party reimbursement consultant for CTI,s product...
(Date:11/19/2009)...EATTLE, Nov. 19 Omeros C...ted financial results for the third quarter ended ...tember 30, 2009, Omeros reported a net loss of $3....t loss of $7.4 million, or $2.54 per share, for th...eptember 30, 2009, the Company reported a net loss...
Breaking Biology Technology:Inimex Announces Appointment of New CEO 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8...ug Royalty LP 2 (DRC) announced,today the purchase...rldwide,royalty interest in PEG-INTRON for $92.5M.... 2012 should certain royalty recognition levels be...oved for the treatment of,Hepatitis C and is marke.... Speaking on behalf of DRC, Paul Kirkconnell, Ma...
...Aug. 27 NeurogesX, Inc.,(Nasdaq: NGSX ), a bioph...ain management therapies, announced today that it ...the Biotech Industry Conference on Thursday,Septem...Executive Officer,and Stephen Ghiglieri, Chief Fin...hursday, September 6, 2007 Time: 2:00 p.m. ...
...DA and Committed to Addressing Unmet Needs of ... - - Conference Call Scheduled for 4:3... Inc.,(Nasdaq: IDMI ) announced today that it rec...nd Drug Administration (FDA) after completing the,...nvestigational drug,mifamurtide (L-MTP-PE), former...
Other Biology Technology:Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN) 2NeurogesX to Present at BioCentury's NewsMakers in the Biotech Industry Conference 2NeurogesX to Present at BioCentury's NewsMakers in the Biotech Industry Conference 3IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 2IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 3IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 4IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 5IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 6IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma 7... The earliest humans almost certainly walked uprig...en half the speed of modern man, new research sugg...nted to the BA (British Association for the Advanc...uesday proposes that if early humans lacked an Ac...hen their ability to run would have been severely ...
...COKEEK, Md., Sept. 10 Beretta U.S.A. Corp. announ...U.S. Army and U.S. Navy for a,total of 10,576 M9 p...he,purchase orders were issued against a multi-yea...y, which serves as executive purchasing agent of t...rces. "We are always honored to be given the oppo...
...nference Embarks on New Strategic Direction in 21s... and HDD Suppliers Under One Roof, SUNNYVALE, Cal...nd its robust dynamic supply chain, IDEMA today an...he premier storage industry event, to be,held on S...a Clara,Convention Center in Santa Clara, Californ...
Other Biology News:Was ability to run early man's Achilles heel? 2Was ability to run early man's Achilles heel? 3U.S. Army and Navy Purchase Over 10,000 New Beretta M9 Pistols 2IDEMA Reveals Program Highlights for DISKCON USA 2007 2IDEMA Reveals Program Highlights for DISKCON USA 2007 3IDEMA Reveals Program Highlights for DISKCON USA 2007 4Mouse Anti-beta-lactoglobulin Monoclonal Antibody, Unconjugated, Clone CD-2 from Cosmo Bio Co., Ltd.
...ti-AP-2 α, clone 8G8/5 GenBank Accession Nu...an AP-2alpha/gamma fusion protein corresponding to...s 278-450 of human AP-2γ Formulation: 0.1M T...e before the addition of glycerol to 30% Quality A...
MMP-2/MMP-9 Inhibitor IV [SB-3CT] from CHEMICON
Costar 6 Well Cell Culture Plate, 9.5 cm2, 34.8 mm Diam. Well, Sterile from Sigma-Aldrich
Biology Products: